These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15563852)

  • 1. Ductal carcinoma in situ presenting as microcalcifications: the effect of stereotactic large-core needle biopsy on surgical therapy.
    de Roos MA; Pijnappel RM; Groote AD; de Vries J; Post WJ; Baas PC
    Breast; 2004 Dec; 13(6):461-7. PubMed ID: 15563852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vacuum-assisted large-core needle biopsy (VLNB) improves the management of patients with breast microcalcifications - analysis of 1009 cases.
    Sigal-Zafrani B; Muller K; El Khoury C; Varoutas PC; Buron C; Vincent-Salomon A; Alran S; Livartowski A; Neuenschwander S; Salmon RJ;
    Eur J Surg Oncol; 2008 Apr; 34(4):377-81. PubMed ID: 17604937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience.
    Killebrew LK; Oneson RH
    Breast J; 2006; 12(4):302-8. PubMed ID: 16848839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device.
    Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH
    Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
    Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
    Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stereotactic large core needle biopsy for the diagnosis of nonpalpable breast lesions: reliable without additional excision biopsy].
    Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
    Ned Tijdschr Geneeskd; 2003 May; 147(18):868-73. PubMed ID: 12756878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous benign-appearing calcifications in patients with ductal carcinoma in situ may not be benign.
    Tabrizian P; Moezzi M; Menes TS
    Breast Cancer; 2011 Oct; 18(4):314-8. PubMed ID: 20602184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting successful breast conservation for ductal carcinoma in situ.
    Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
    Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy.
    Chen AM; Haffty BG; Lee CH
    Radiology; 2002 Dec; 225(3):707-12. PubMed ID: 12461249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
    Eby PR; Ochsner JE; DeMartini WB; Allison KH; Peacock S; Lehman CD
    Ann Surg Oncol; 2008 Nov; 15(11):3232-8. PubMed ID: 18696163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.